AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta)... Show more
ABBV is expected to pay dividends on August 15, 2025
A dividend of $1.64 per share will be paid with a record date of August 15, 2025, and an ex-dividend date of July 15, 2025. The last dividend of $1.64 was paid on May 15. Read more...
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ABBV showed earnings on July 31, 2025. You can read more about the earnings report here.